- Home
- XHG vs ZLAB Comparison
XHG vs ZLAB Comparison
Compare XHG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XHG
- ZLAB
- Stock Information
- Founded
- XHG 2012
- ZLAB 2013
- Country
- XHG China
- ZLAB China
- Employees
- XHG N/A
- ZLAB N/A
- Industry
- XHG
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- XHG
- ZLAB Health Care
- Exchange
- XHG NYSE
- ZLAB Nasdaq
- Market Cap
- XHG 66.8M
- ZLAB 3.6B
- IPO Year
- XHG 2019
- ZLAB 2017
- Fundamental
- Price
- XHG $1.43
- ZLAB $35.19
- Analyst Decision
- XHG
- ZLAB Buy
- Analyst Count
- XHG 0
- ZLAB 5
- Target Price
- XHG N/A
- ZLAB $54.28
- AVG Volume (30 Days)
- XHG 124.0K
- ZLAB 689.4K
- Earning Date
- XHG 07-25-2025
- ZLAB 08-07-2025
- Dividend Yield
- XHG N/A
- ZLAB N/A
- EPS Growth
- XHG N/A
- ZLAB N/A
- EPS
- XHG N/A
- ZLAB N/A
- Revenue
- XHG $41,110,414.00
- ZLAB $418,326,000.00
- Revenue This Year
- XHG N/A
- ZLAB $44.07
- Revenue Next Year
- XHG N/A
- ZLAB $49.13
- P/E Ratio
- XHG N/A
- ZLAB N/A
- Revenue Growth
- XHG N/A
- ZLAB 43.72
- 52 Week Low
- XHG $1.16
- ZLAB $16.01
- 52 Week High
- XHG $1,200.00
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- XHG 45.20
- ZLAB 49.90
- Support Level
- XHG $1.26
- ZLAB $32.31
- Resistance Level
- XHG $1.43
- ZLAB $35.72
- Average True Range (ATR)
- XHG 0.10
- ZLAB 1.10
- MACD
- XHG 0.08
- ZLAB -0.34
- Stochastic Oscillator
- XHG 97.82
- ZLAB 60.17
About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)
XChange Tec Inc, through its subsidiaries operates in insurance agency and insurance technology business. The company specialized in distributing automobile insurance policies at the earlier stage of business and subsequently expanded insurance product portfolio to include other types of insurance including life, health, group accident and other property related insurances. A maximum of the insurance purchased through platform and agency services is of automobile insurance.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.